Department of Nephrology, Instituto Nacional de Cardiologia Ignacio Chavez, México City, Mexico.
Diabetes Res Clin Pract. 2011 Oct;94(1):e8-11. doi: 10.1016/j.diabres.2011.06.023. Epub 2011 Jul 20.
We observed that in isolated perfused rat kidneys, sphingosine-1-phosphate produces S1P(2) receptor-mediated vasoconstriction, and this response increased in kidneys of diabetic rats. These results suggest that the antagonists of S1P(2) receptor may have potential as drugs to control diabetes-induced vascular complications.
我们观察到,在分离的灌注大鼠肾脏中,鞘氨醇-1-磷酸产生 S1P(2) 受体介导的血管收缩,并且这种反应在糖尿病大鼠的肾脏中增加。这些结果表明,S1P(2) 受体拮抗剂可能具有作为控制糖尿病引起的血管并发症的药物的潜力。